1 – 17 of 17
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex
(
- Contribution to journal › Article
- 2020
-
Mark
Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays
(
- Contribution to journal › Article
- 2018
-
Mark
Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
(
- Contribution to journal › Article
-
Mark
Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention
(
- Contribution to journal › Article
- 2015
-
Mark
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
(
- Contribution to journal › Article
- 2014
-
Mark
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.
(
- Contribution to journal › Article
-
Mark
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
(
- Contribution to journal › Article
-
Mark
The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease
(
- Contribution to journal › Article
- 2013
-
Mark
Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
(
- Contribution to journal › Article
- 2011
-
Mark
In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis.
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
(
- Contribution to journal › Article
- 2010
-
Mark
Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study
(
- Contribution to journal › Article
-
Mark
Increased Factor Viii Activity In Portal Vein Thrombosis And Budd-Chiari Syndrome
2010) 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases In Hepatology 52(4). p.1217-1217(
- Contribution to journal › Published meeting abstract
- 2006
-
Mark
Calibration services in the frame of accredited coagulation EQA schemes - Meeting the IVD directive
(
- Contribution to journal › Article
- 2004
-
Mark
Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme.
(
- Contribution to journal › Article
- 2002
-
Mark
Mer samstämmiga laboratorieresultat efter övergången till INR. Skillnaderna mellan sjukhus- och primärvårdslaboratorier utjämnade
(
- Contribution to journal › Article
- 1999
-
Mark
Samordnad svensk övergång rekommenderas under 1999. Protrombinkomplexmätning bör anges som en kvot, inte i procent
(
- Contribution to journal › Article